Related Experiment Video

Updated: Dec 8, 2025

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.4K

Nanotechnology for multimodality treatment of cancer

Xiao-Ying Zhang, Pei-Ying Zhang

    Oncology Letters
    |September 24, 2020
    PubMed

    Abstract:

    [This retracts the article DOI: 10.3892/ol.2016.5322.].

    More Related Videos

    Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
    09:02

    Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

    Published on: September 27, 2024

    3.0K
    Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
    07:25

    Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

    Published on: March 1, 2024

    2.8K

    Related Experiment Videos

    Last Updated: Dec 8, 2025

    Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
    09:01

    Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

    Published on: May 22, 2020

    3.4K
    Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
    09:02

    Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

    Published on: September 27, 2024

    3.0K
    Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
    07:25

    Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

    Published on: March 1, 2024

    2.8K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    8.4K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    8.4K
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    5.7K
    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    5.7K

    Articles linked to this work by shared authors, journal, and citation graph.

    NOD1 ligand FK565 promotes atherogenesis and accumulation of NOD1+ smooth muscle cells in atherosclerotic lesions.

    Atherosclerosis·2026

    [Retracted] Recent perspectives of electronic medical record systems (Review).

    Experimental and therapeutic medicine·2026

    [Retracted] Telemedicine in clinical setting (Review).

    Experimental and therapeutic medicine·2026

    Efgartigimod as an Add-on Therapy for Anti-IgLON5 Disease: A Case Report.

    Neurology and therapy·2026

    Whole-Exome Profiling of Epstein-Barr Virus-Positive Neuroendocrine Carcinoma of the Nasopharynx.

    Endocrine pathology·2026

    Incidence and disease spectrum of inherited metabolic diseases screened by tandem mass spectrometry in Huai'an from 2018 to 2024.

    Frontiers in pediatrics·2025

    Erratum: [Corrigendum] MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A.

    Oncology letters·2026

    Effect of perioperative nutritional status, inflammatory response and postoperative chemotherapy on survival after gastrectomy for advanced gastric cancer.

    Oncology letters·2026

    Boost delivery in hypofractionated breast cancer radiotherapy: A registry-based analysis of treatment patterns and survival.

    Oncology letters·2026

    Preoperative CA125 and metabolic factors associated with high-risk pathology in endometrial cancer.

    Oncology letters·2026

    Metabolic heterogeneity and functional diversity of cancer-associated fibroblasts in gastric cancer (Review).

    Oncology letters·2026

    OLFML2A expression in acute myeloid leukemia, with exploratory findings in acute lymphoblastic leukemia: Prognostic significance and re-analysis of public single-cell transcriptomic data.

    Oncology letters·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us